New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization The peptide problem: Hype is outrunning the evidence Q&A: Should you trust trending peptide injections? Compounded "semaglutide" is not FDA approved semaglutide.com The peptide problem: Hype is outrunning the evidence